Despite an increase in access to medicines in low- and middle-income countries (LMICs), fully functional pharmacovigilance and regulatory systems are not yet in place. Strengthening regulatory and pharmacovigilance systems is a global imperative for preventing harm and improving outcomes in treatment and prevention programs. The Asia region both supplies and purchases medical products. A better … Read more
